Pinglong Xu

4.3k total citations · 2 hit papers
79 papers, 2.9k citations indexed

About

Pinglong Xu is a scholar working on Molecular Biology, Immunology and Infectious Diseases. According to data from OpenAlex, Pinglong Xu has authored 79 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Molecular Biology, 33 papers in Immunology and 16 papers in Infectious Diseases. Recurrent topics in Pinglong Xu's work include interferon and immune responses (29 papers), Inflammasome and immune disorders (13 papers) and Viral Infections and Vectors (11 papers). Pinglong Xu is often cited by papers focused on interferon and immune responses (29 papers), Inflammasome and immune disorders (13 papers) and Viral Infections and Vectors (11 papers). Pinglong Xu collaborates with scholars based in China, United States and Germany. Pinglong Xu's co-authors include Rik Derynck, Chen Chen, Xin‐Hua Feng, Jianming Liu, Ruyuan Zhou, Xia Lin, Shengduo Liu, Shasha Chen, Jian Zou and Qian Zhang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Pinglong Xu

71 papers receiving 2.9k citations

Hit Papers

Cellular functions of cGAS-STING signaling 2022 2026 2023 2024 2022 2022 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pinglong Xu China 30 1.7k 1.1k 601 385 352 79 2.9k
Ramón Garcı́a-Escudero Spain 33 1.6k 1.0× 598 0.5× 828 1.4× 195 0.5× 234 0.7× 82 3.2k
Abul Bashar Mir Md. Khademul Islam Bangladesh 30 1.7k 1.0× 441 0.4× 485 0.8× 201 0.5× 293 0.8× 87 2.6k
Yves Lepelletier France 33 1.6k 1.0× 2.1k 1.9× 698 1.2× 181 0.5× 148 0.4× 68 4.2k
Matthew Staron United States 17 2.0k 1.2× 2.8k 2.5× 973 1.6× 286 0.7× 261 0.7× 21 4.5k
Nicolas Bidère France 26 2.0k 1.2× 1.4k 1.3× 484 0.8× 298 0.8× 115 0.3× 59 3.3k
Michael Basler Germany 32 2.6k 1.5× 1.4k 1.3× 1.1k 1.9× 324 0.8× 142 0.4× 75 3.7k
Agustı́n Valenzuela-Fernández Spain 26 1.2k 0.7× 704 0.6× 680 1.1× 327 0.8× 467 1.3× 51 2.7k
Ronnie Blecher‐Gonen Israel 14 1.5k 0.9× 1.7k 1.5× 315 0.5× 92 0.2× 250 0.7× 19 3.2k
Aifu Lin China 32 2.1k 1.2× 843 0.7× 279 0.5× 260 0.7× 341 1.0× 85 3.3k
Raul M. Torres United States 36 1.5k 0.9× 3.2k 2.8× 492 0.8× 190 0.5× 208 0.6× 103 4.9k

Countries citing papers authored by Pinglong Xu

Since Specialization
Citations

This map shows the geographic impact of Pinglong Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pinglong Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pinglong Xu more than expected).

Fields of papers citing papers by Pinglong Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pinglong Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pinglong Xu. The network helps show where Pinglong Xu may publish in the future.

Co-authorship network of co-authors of Pinglong Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Pinglong Xu. A scholar is included among the top collaborators of Pinglong Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pinglong Xu. Pinglong Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Meng, Ying, Saskia Heybrock, Qiang Zhao, et al.. (2025). Sphingosine-1-phosphate signalling activates E-Syt1 to facilitate HDL-derived cholesterol transport. Nature Cell Biology. 27(6). 918–930.
2.
Ji, Fubo, Xianglei He, Yongzhi Zhao, et al.. (2025). Liver-specific gene PGRMC1 blocks c-Myc-induced hepatocarcinogenesis through ER stress-independent PERK activation. Nature Communications. 16(1). 50–50. 4 indexed citations
3.
Li, Boran, Xinyi Wang, Xiao Jiang, et al.. (2025). Cholesterol sensing by the SCAP–FAM134B complex regulates ER-phagy and STING innate immunity. Nature Cell Biology. 27(10). 1739–1756.
4.
Tu, Yingfeng, Min Tang, Li Gao, et al.. (2024). TBC1D23 mediates Golgi-specific LKB1 signaling. Nature Communications. 15(1). 1785–1785. 16 indexed citations
5.
Xu, Pinglong, et al.. (2024). Role of micronucleus-activated cGAS-STING signaling in antitumor immunity. Journal of Zhejiang University (Medical Sciences). 53(1). 25–34. 3 indexed citations
6.
Li, Xinran, Pinglong Xu, Qiming Sun, et al.. (2024). S-acylation of ATGL is required for lipid droplet homoeostasis in hepatocytes. Nature Metabolism. 6(8). 1549–1565. 17 indexed citations
7.
Wu, Shiying, Pinglong Xu, & Fei Zhang. (2024). Advances in targeted therapy for gastric cancer based on tumor driver genes. Journal of Zhejiang University (Medical Sciences). 53(1). 73–83.
8.
Xiao, Mu, Fei Wang, Jin Cao, et al.. (2023). Smad4 sequestered in SFPQ condensates prevents TGF-β tumor-suppressive signaling. Developmental Cell. 59(1). 48–63.e8. 17 indexed citations
9.
Wang, Lijing, Shuchen Gu, Fenfang Chen, et al.. (2023). Imatinib blocks tyrosine phosphorylation of Smad4 and restores TGF-β growth-suppressive signaling in BCR-ABL1-positive leukemia. Signal Transduction and Targeted Therapy. 8(1). 120–120. 9 indexed citations
10.
Yuan, Bo, Jinquan Liu, Aiping Shi, et al.. (2023). HERC3 promotes YAP / TAZ stability and tumorigenesis independently of its ubiquitin ligase activity. The EMBO Journal. 42(4). e111549–e111549. 19 indexed citations
11.
Xu, Yifan, Chen Chen, Zhiyong Liao, & Pinglong Xu. (2023). cGAS‐STING signaling in cell death: Mechanisms of action and implications in pathologies. European Journal of Immunology. 53(9). e2350386–e2350386. 30 indexed citations
12.
Zhang, Dan, Yutong Liu, Yezhang Zhu, et al.. (2022). A non-canonical cGAS–STING–PERK pathway facilitates the translational program critical for senescence and organ fibrosis. Nature Cell Biology. 24(5). 766–782. 163 indexed citations breakdown →
13.
Liu, Jinquan, Bo Yuan, Jin Cao, et al.. (2021). AMBRA1 Promotes TGFβ Signaling via Nonproteolytic Polyubiquitylation of Smad4. Cancer Research. 81(19). 5007–5020. 14 indexed citations
14.
Qin, Qiang, Mengjie Li, Zhuo‐Xian Meng, et al.. (2021). Stk24 protects against obesity-associated metabolic disorders by disrupting the NLRP3 inflammasome. Cell Reports. 35(8). 109161–109161. 17 indexed citations
15.
Gao, Chun, Xinran Li, Shuchen Gu, et al.. (2021). HSPA13 facilitates NF-κB–mediated transcription and attenuates cell death responses in TNFα signaling. Science Advances. 7(41). eabh1756–eabh1756. 8 indexed citations
16.
Chen, Shasha, Shengduo Liu, Jun‐Xian Wang, et al.. (2020). TBK1-Mediated DRP1 Targeting Confers Nucleic Acid Sensing to Reprogram Mitochondrial Dynamics and Physiology. Molecular Cell. 80(5). 810–827.e7. 42 indexed citations
17.
Tian, Miao, Xiumei Wang, Jihong Sun, et al.. (2020). IRF3 prevents colorectal tumorigenesis via inhibiting the nuclear translocation of β-catenin. Nature Communications. 11(1). 5762–5762. 64 indexed citations
18.
Wu, Shiying, Qian Zhang, Fei Zhang, et al.. (2019). HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity. Nature Cell Biology. 21(8). 1027–1040. 192 indexed citations
19.
Zhang, Qian, Xia Lin, Shiying Wu, et al.. (2016). PPM1A silences cytosolic RNA sensing and antiviral defense through direct dephosphorylation of MAVS and TBK1. Science Advances. 2(7). e1501889–e1501889. 57 indexed citations
20.
Chen, Fenfang, Xia Lin, Pinglong Xu, et al.. (2015). Nuclear Export of Smads by RanBP3L Regulates Bone Morphogenetic Protein Signaling and Mesenchymal Stem Cell Differentiation. Molecular and Cellular Biology. 35(10). 1700–1711. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026